Table 3.
Comp. | Type | R1 | ENT1 inhibitory activity in K562 cells determined by flow cytometry | ||
---|---|---|---|---|---|
%Inhibition at 10μM | IC50 (nM) | Ki (nM) | |||
DMSO | - | - | 0.0 ± 0.7 | ND a | ND |
NBMPR | - | - | 97.1 ± 0.4 | 7.6 | 0.43 |
Lidoflazine | - | - | 90.0 ± 0.2 | 4954 | 279.9 |
DP | A | 86.7 ± 0.1 | 144.8 | 8.18 | |
39 | A | NH2 | 6.5 ± 0.1 | ND | ND |
40 | A | MeNH | 4.1 ± 0.9 | ND | ND |
41 | B | -1.0 ± 0.1 | ND | ND | |
42 | A | EtNH | 24.0 ± 1.0 | ND | ND |
43 | B | 0.7 ± 0.5 | ND | ND | |
44 | A | n-PropylNH | 79.5 ± 1.0 | 5,310 | 300 |
45 | B | 5.7 ± 0.3 | ND | ND | |
46 | A | iso-PropylNH | 81.7 ± 1.4 | 3,381 | 191 |
47 | B | 14.1 ± 1.2 | ND | ND | |
48 | A | n-ButylNH | 87.3 ± 0.1 | 2,407 | 136 |
49 | B | 61.6 ± 0.1 | 8,655 | 489 | |
50 | A | iso-ButylNH | 92.0 ± 0.2 | 673 | 38 |
51 | B | 24.9 ± 0.1 | ND | ND | |
52 | A | tert-ButylNH | 81.2 ± 0.1 | 297 | 16.8 |
53 | B | 28.0 ± 0.1 | ND | ND | |
54 | A | n-PentylNH | 56.4 ± 0.4 | 2,476 | 139.9 |
55 | B | 12.5 ± 1.4 | ND | ND | |
56 | A | iso-PentylNH | 86.8 ± 0.6 | 2,136 | 120.7 |
57 | B | 7.56 ± 0.1 | ND | ND | |
58 | A | tert-PentylNH | 94.4 ± 0.2 | 260 | 14.7 |
59 | B | 16.1 ± 0.3 | ND | ND | |
60 | A | 48.7± 0.9 | 7,554 | 427.6 | |
61 | B | 6.2 ± 1.3 | ND | ND | |
62 | A | 84.1 ± 0.3 | 1,838 | 104.1 | |
63 | B | 23.0 ± 2.6 | ND | ND | |
64 | A | 90.8 ± 0.2 | 279.7 | 15.8 | |
65 | B | 4.9 ± 0.2 | ND | ND | |
66 | A | 80.9 ± 0.1 | 940 | 53.1 | |
67 | B | 1.4 ± 0.3 | ND | ND | |
68 | A | 5.8 ± 0.5 | ND | ND | |
69 | B | 6.6 ± 3.9 | ND | N. D. | |
70 | A | 11.9 ± 1.8 | ND | ND | |
71 | B | 3.8 ± 0.2 | ND | ND |
ND = Not Determined.